Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Replimune Group, Inc. Director's Dealing 2024

Aug 31, 2024

33193_dirs_2024-08-30_a4f806b2-058f-4343-9171-ac6b2310a78c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2024-08-30

Reporting Person: Astley-Sparke Philip (Director, Executive Chairman)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-08-30 Common Stock G 50000 Disposed 1437350 Direct